CL2013003066A1 - Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion - Google Patents

Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion

Info

Publication number
CL2013003066A1
CL2013003066A1 CL2013003066A CL2013003066A CL2013003066A1 CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1 CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1
Authority
CL
Chile
Prior art keywords
composition
wounds
mesenchymics
treatment
applying
Prior art date
Application number
CL2013003066A
Other languages
English (en)
Inventor
Alvarado Veronica Alejandra Palma
Merino Maria Rosa Bono
Original Assignee
Univ Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chile filed Critical Univ Chile
Priority to CL2013003066A priority Critical patent/CL2013003066A1/es
Publication of CL2013003066A1 publication Critical patent/CL2013003066A1/es
Priority to PCT/CL2014/000055 priority patent/WO2015058318A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

LA INVEN´CIÓN PROPORCIONA UNA COMPOSICION PARA TRATAMIENTO DE HERIDAS PORQUE COMPRENDE MATRIZ SOPORTE Y CÉLULAS TRONCALESMESENQUIÁMICAS DE GELATINA DE WHARTON; METODO PARA TRATAR HERIDAS QUE COMPRENDE APLICAR DICHA COMPOSICION
CL2013003066A 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion CL2013003066A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2013003066A CL2013003066A1 (es) 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
PCT/CL2014/000055 WO2015058318A1 (es) 2013-10-22 2014-10-20 Composición para acelerar o mejorar la cicatrización en heridas, y un método para acelerar o mejorar la cicatrización en heridas que comprende aplicar dicha composición

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2013003066A CL2013003066A1 (es) 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion

Publications (1)

Publication Number Publication Date
CL2013003066A1 true CL2013003066A1 (es) 2014-07-25

Family

ID=52020872

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003066A CL2013003066A1 (es) 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion

Country Status (2)

Country Link
CL (1) CL2013003066A1 (es)
WO (1) WO2015058318A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106310369A (zh) * 2016-09-29 2017-01-11 广州赛莱拉干细胞科技股份有限公司 一种组合物、含有该组合物的3d敷料及其制备方法
EP3456363B1 (en) * 2017-09-18 2020-11-04 Banc De Sang I Teixits Composition for regenerating bony tissue, method for preparation and use thereof
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
CN111760064A (zh) * 2020-08-25 2020-10-13 重庆大学附属肿瘤医院 一种用于治疗糖尿病足的敷料及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012205269B2 (en) 2004-03-22 2015-08-27 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
US8709081B2 (en) * 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
KR101101321B1 (ko) 2008-11-03 2012-01-02 주식회사 엠씨티티 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
WO2010062297A1 (en) 2008-11-25 2010-06-03 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Regenerative tissue grafts and methods of making same
KR101109125B1 (ko) 2009-03-24 2012-02-15 한국과학기술연구원 줄기세포를 혈관세포로 분화시키는 방법 및 이를 이용한 생체 내 혈관신생 유도
ES2677945T3 (es) * 2009-08-25 2018-08-07 Servicio Andaluz De Salud Producción de tejidos artificiales mediante ingeniería tisular utilizando biomateriales de fibrina y agarosa
CN102892880A (zh) * 2010-01-14 2013-01-23 奥加诺吉尼西斯公司 生物工程化组织构建物及其制备和使用方法
ITMI20100601A1 (it) * 2010-04-09 2011-10-10 Luisa Benassi "nuovo sostituto dermico e sua applicazione terapeutica"
WO2012131618A1 (en) 2011-03-30 2012-10-04 Stempeutics Research Private Limited A composition comprising pooled wharton's jelly derived mesenchymal stem cells and methods thereof
CN104661666A (zh) * 2012-08-15 2015-05-27 新加坡国立大学 浸渗有人脐带沃顿胶质干细胞的伤口敷料纳米筛

Also Published As

Publication number Publication date
WO2015058318A1 (es) 2015-04-30

Similar Documents

Publication Publication Date Title
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
BR112017018234A2 (pt) inibidores de pd-1 / pd-l1 para o tratamento de câncer
BR112017018954A2 (pt) uso de forma mutante de proteína ras e método para tratar câncer
CL2015002708A1 (es) Compuestos heterocíclicos y sus usos.
CL2015000699A1 (es) Métodos para tratamiento de cáncer.
BR112017016019A2 (pt) método para tratamento de câncer, artigo para fabricação, e, kit.
CL2015002754A1 (es) Método para descelularización de injertos de tejido
CR20160308A (es) Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
MX2017013199A (es) Composiciones para modular la expresion de c90rf72.
BR112013017506A2 (pt) dispositivos e métodos de tratamento de feridas e da pele
CR20120413A (es) Derivados de fumarato de ácido graso y sus usos
CL2015002807A1 (es) Terapia de combinación
CR20140573A (es) Inhibidores del nampt
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
CL2018001258A1 (es) Métodos para tratar las condiciones asociadas con la activación del complemento dependiente de masp-2
CL2017002774A1 (es) Secuencias de uricasa mejorada y métodos de tratamiento
BR112013023227A2 (pt) método para tratar perda de circulação, e material de circulação perdida de gelificação (lcm)
EA201792496A1 (ru) Способы лечения воспаления или нейропатической боли
EP3466447A4 (en) PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE SUITABLE FOR THE TREATMENT OF MULTIPLE SKIN ULCERS
EP3194013A4 (en) A wound care bandage and method of wound healing
CL2015002723A1 (es) Métodos para tratar la psoriasis utilizando un anticuerpo anti-il-23
CL2013003066A1 (es) Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
UY34070A (es) Método y composición para tratamiento de semillas.
UY37534A (es) Metodo para el tratamiento de enfermedades fibroticas utilizando el interferon-lambda
UY36173A (es) Metodo de tratamiento de enfermedades relacionadas con el factor inducible por hipoxia